Eubel Brady & Suttman Asset Management Inc. Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Eubel Brady & Suttman Asset Management Inc. boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 32.9% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,083,539 shares of the pharmacy operator’s stock after buying an additional 268,262 shares during the quarter. Walgreens Boots Alliance accounts for approximately 1.9% of Eubel Brady & Suttman Asset Management Inc.’s holdings, making the stock its 26th biggest position. Eubel Brady & Suttman Asset Management Inc. owned approximately 0.13% of Walgreens Boots Alliance worth $13,105,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of WBA. Atlas Brown Inc. increased its position in shares of Walgreens Boots Alliance by 1.8% during the 1st quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock valued at $685,000 after purchasing an additional 550 shares during the last quarter. Westpac Banking Corp increased its position in shares of Walgreens Boots Alliance by 10.1% during the 4th quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after purchasing an additional 560 shares during the last quarter. Shilanski & Associates Inc. increased its position in shares of Walgreens Boots Alliance by 5.3% during the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after purchasing an additional 591 shares during the last quarter. First Trust Direct Indexing L.P. increased its position in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after purchasing an additional 597 shares during the last quarter. Finally, NBC Securities Inc. increased its position in shares of Walgreens Boots Alliance by 9.9% during the 4th quarter. NBC Securities Inc. now owns 6,757 shares of the pharmacy operator’s stock valued at $176,000 after purchasing an additional 611 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

WBA stock opened at $8.92 on Tuesday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.46 and a 1-year high of $27.05. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The business has a 50 day simple moving average of $10.70 and a two-hundred day simple moving average of $15.46.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion during the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter in the previous year, the company earned $1.00 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, August 21st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.21%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Barclays reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. TD Cowen cut their price objective on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Monday, July 1st. Finally, JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research note on Friday, August 30th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $15.19.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.